GOCO Stock Recent News
GOCO LATEST HEADLINES
GoHealth, Inc. (NASDAQ:GOCO ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants John E. Shave - Vice President of Investor Relations Vijay Kumar Kotte - CEO & Director Conference Call Participants David Joseph Storms - Stonegate Capital Partners, Inc., Research Division Ilya Zubkov - Freedom Broker, Research Division James Philip Sidoti - Sidoti & Company, LLC Patrick Joseph McCann - NOBLE Capital Markets, Inc., Research Division Robert Miles McGuire - Granite Research, LLC Operator Good day, and welcome to the GoHealth Second Quarter 2025 Earnings Conference Call.
Dallas, Texas--(Newsfile Corp. - August 8, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a challenged second quarter in 2025, highlighted by revenue declines and contracting margins.
Presentation Operator MessageOperator (Operator)Good day and welcome to the GoHealth Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I
GoHealth (GOCO) came out with a quarterly loss of $1.23 per share versus the Zacks Consensus Estimate of a loss of $2.6. This compares to a loss of $0.75 per share a year ago.
CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025.
NEW YORK, July 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.
NEW YORK , July 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.
NEW YORK , July 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.